RHHBY Roche Holding AG
Company Analysis
Latest News
π΄ Roche is trading 3.01% down today as tensions push Brent crude toward $90
Roche is trading 3.01% down at $53.53 amid broad risk-off sentiment on August 31, 2026, as renewed Middle East tensions pushed Brent crude toward $90 and...
Roche Vabysmo sustains vision gains, extending treatment to 20-week intervals
Roche released two-year data from the Phase IIIb/IV SALWEEN study of Vabysmo (faricimab). The treatment demonstrated significant improvements in vision and...
π’ Roche is trading 5% up today as healthcare stocks rally
Roche is trading 4.81% up now at $58.20, outperforming the broader market as healthcare stocks rally. - Healthcare ETF XLV is up 3.23% during the regular...
π’ Roche is trading 3.75% up today as healthcare stocks rallied broadly
Roche is trading at $57.55, up 3.75%, after a broad healthcare-stock rally on August 19, 2026. - The advance reflects stronger earnings expectations, easing...
π’ Roche is trading 3.48% up today as healthcare stocks rally
Roche is trading 3.48% up now at $57.46 as healthcare stocks rally. - Stronger earnings expectations, favorable regulatory conditions, FDA approval activity,...
Roche to acquire PathAI for $1.05B, targeting AI-driven diagnosis
Swiss pharmaceutical group Roche agreed to acquire PathAI. PathAI is a U.S.-based specialist in artificial intelligence-powered pathology diagnostics. The...
Roche Deploys 3,500 Nvidia Blackwell GPUs, Creating Pharmaβs Largest AI Factory
Roche deployed over 3,500 Nvidia Blackwell GPUs to establish a powerful AI factory. This move creates the largest announced GPU footprint in the pharmaceutical...